Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptamer Group Share News (APTA)

Share Price Information for Aptamer Group (APTA)

Share Price is delayed by 15 minutes
Get Live Data
0.525    -0.025 (-4.55%)
Bid:
0.50
Ask:
0.55
Spread: 0.05 (10.00%)
Market Cap: £18.14m
APTA Live PriceLast checked at - London Stock Exchange

Intraday Aptamer Group Share Chart

Aptamer Group News

IN BRIEF: DeepVerge rises on wastewater monitoring system deployment
28 Mar 2022

IN BRIEF: DeepVerge rises on wastewater monitoring system deployment

Deepverge PLC - Dublin-based environmental and life science group - Says that the first six installations of Modern Water Post-Pandemic Microtox PD pa...

TRADING UPDATES: Victorian Plumbing margin warning; Amigo in profit
24 Feb 2022

TRADING UPDATES: Victorian Plumbing margin warning; Amigo in profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

LONDON BROKER RATINGS: RBC raises Fresnillo; Berenberg cuts Hargreaves
24 Feb 2022

LONDON BROKER RATINGS: RBC raises Fresnillo; Berenberg cuts Hargreaves

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

TRADING UPDATES: Inland's Hillingdon boost; Yooma products at Boots
17 Jan 2022

TRADING UPDATES: Inland's Hillingdon boost; Yooma products at Boots

TRADING UPDATES: Inland's Hillingdon boost; Yooma products at Boots

Liberum claims top spot among brokers for AIM IPOs in 2021
24 Dec 2021

Liberum claims top spot among brokers for AIM IPOs in 2021

Liberum claims top spot among brokers for AIM IPOs in 2021

CORRECT: Life sciences firm Aptamer rises 24% in AIM debut
22 Dec 2021

CORRECT: Life sciences firm Aptamer rises 24% in AIM debut

CORRECT: Life sciences firm Aptamer rises 24% in AIM debut

IN BRIEF: Life sciences firm Aptamer rises 24% in AIM debut
22 Dec 2021

IN BRIEF: Life sciences firm Aptamer rises 24% in AIM debut

IN BRIEF: Life sciences firm Aptamer rises 24% in AIM debut